Optovue receives FDA clearance of iCam

Article

Optovue has received 510(k) clearance for its iCam non-mydriatic, compact fundus camera.

 

Fremont, CA-Optovue has received 510(k) clearance for its iCam non-mydriatic, compact fundus camera.

The iCam produces 45-degree color fundus images of the eye as well as external ocular structures. iCam includes a variety of functions and features that produce high-quality image documentation and management of ocular health. A 12-bit CCD image sensor provides deep, rich colors with lower noise than 8-bit CMOS sensors. An LED light source is used for reduced peak light energy to the eye as well as longer life.

The device includes simple joystick control, focusing and positioning aids to expedite the photography process while an easy user interface enables image review and EMR communication.

iCam is expected to release to the U.S. market in Q2, followed by a global release.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.